Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
An overview is given on the diverse uses of computational chemistryin drug discovery. Particular emphasis is placed on virtualscreening, de novo design, evaluation of drug-likeness, andadvanced methods for determining protein-ligand binding.
Department of Chemistry, Yale University, New Haven, CT 06520-8107, USA.
The editors suggest the following Related Resources on Science sites:
In Science Magazine
INTRODUCTION TO SPECIAL ISSUE
Phil Szuromi, Valda Vinson, and Eliot Marshall (19 March 2004) Science303 (5665), 1795.
[DOI: 10.1126/science.303.5665.1795] |Summary »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Calculation of protein-ligand binding free energy by using a polarizable potential.
D. Jiao, P. A. Golubkov, T. A. Darden, and P. Ren (2008)
PNAS
105, 6290-6295
|Abstract »|Full Text »|PDF »
Potent and selective inhibitors of Staphylococcus epidermidis tryptophanyl-tRNA synthetase.
Y. Wu, K. Yu, B. Xu, L. Chen, X. Chen, J. Mao, A. Danchin, X. Shen, D. Qu, and H. Jiang (2007)
J. Antimicrob. Chemother.
60, 502-509
|Abstract »|Full Text »|PDF »
Structurally Unique Inhibitors of Human Mitogen-Activated Protein Kinase Phosphatase-1 Identified in a Pyrrole Carboxamide Library.
J. S. Lazo, J. J. Skoko, S. Werner, B. Mitasev, A. Bakan, F. Koizumi, A. Yellow-Duke, I. Bahar, and K. M. Brummond (2007)
J. Pharmacol. Exp. Ther.
322, 940-947
|Abstract »|Full Text »|PDF »
Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design.
L. A. Clark, P. A. Boriack-Sjodin, J. Eldredge, C. Fitch, B. Friedman, K. J.M. Hanf, M. Jarpe, S. F. Liparoto, Y. Li, A. Lugovskoy, et al. (2006)
Protein Sci.
15, 949-960
|Abstract »|Full Text »|PDF »
Crystal Structures of Two Bacterial 3-Hydroxy-3-methylglutaryl-CoA Lyases Suggest a Common Catalytic Mechanism among a Family of TIM Barrel Metalloenzymes Cleaving Carbon-Carbon Bonds.
F. Forouhar, M. Hussain, R. Farid, J. Benach, M. Abashidze, W. C. Edstrom, S. M. Vorobiev, R. Xiao, T. B. Acton, Z. Fu, et al. (2006)
J. Biol. Chem.
281, 7533-7545
|Abstract »|Full Text »|PDF »
Two Domains That Control Prefusion Stability and Transport Competence of the Measles Virus Fusion Protein.
J. Doyle, A. Prussia, L. K. White, A. Sun, D. C. Liotta, J. P. Snyder, R. W. Compans, and R. K. Plemper (2006)
J. Virol.
80, 1524-1536
|Abstract »|Full Text »|PDF »
Calculation of Absolute Protein-Ligand Binding Affinity Using Path and Endpoint Approaches.
C. Fernandez-Tornero, E. Garcia, B. de Pascual-Teresa, R. Lopez, G. Gimenez-Gallego, and A. Romero (2005)
J. Biol. Chem.
280, 19948-19957
|Abstract »|Full Text »|PDF »
Interaction between Cardiac Calsequestrin and Drugs with Known Cardiotoxicity.
I. Y. Park, E. J. Kim, H. Park, K. Fields, A. K. Dunker, and C. Kang (2005)
Mol. Pharmacol.
67, 97-104
|Abstract »|Full Text »|PDF »
Drug Discovery, CAM and Natural Products.
E. L. Cooper (2004)
Evid. Based Complement. Altern. Med.
1, 215-217
|Full Text »|PDF »